| - GRCh37:
- Chr15:40762842
- GRCh38:
- Chr15:40470643
| CHST14 | | not provided | Benign (Jun 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40762862
- GRCh38:
- Chr15:40470663
| CHST14 | | not provided | Benign (Jul 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40762879
- GRCh38:
- Chr15:40470680
| CHST14 | | not provided | Likely benign (Jun 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763228
- GRCh38:
- Chr15:40471029
| CHST14 | | not provided | Likely benign (May 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763386
- GRCh38:
- Chr15:40471187
| CHST14 | | not specified | Likely benign (Aug 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763408
- GRCh38:
- Chr15:40471209
| CHST14 | | not specified | Likely benign (Nov 4, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763414
- GRCh38:
- Chr15:40471215
| CHST14 | M1T | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Nov 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763420
- GRCh38:
- Chr15:40471221
| CHST14 | P3L | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763423
- GRCh38:
- Chr15:40471224
| CHST14 | R4P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763432
- GRCh38:
- Chr15:40471233
| CHST14 | T7N | Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1 | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763435
- GRCh38:
- Chr15:40471236
| CHST14 | P8L | Cardiovascular phenotype | Uncertain significance (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763444
- GRCh38:
- Chr15:40471245
| CHST14 | A11V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763446
- GRCh38:
- Chr15:40471247
| CHST14 | P12S | Cardiovascular phenotype | Uncertain significance (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763449
- GRCh38:
- Chr15:40471250
| CHST14 | N13D | Cardiovascular phenotype | Uncertain significance (Aug 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763455
- GRCh38:
- Chr15:40471256
| CHST14 | A15S | Cardiovascular phenotype | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763455
- GRCh38:
- Chr15:40471256
| CHST14 | A15P | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763457
- GRCh38:
- Chr15:40471258
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Feb 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763458
- GRCh38:
- Chr15:40471259
| CHST14 | E16K | not provided | Uncertain significance (Jan 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763460
- GRCh38:
- Chr15:40471261
| CHST14 | E16D | Cardiovascular phenotype | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763460
- GRCh38:
- Chr15:40471261
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jun 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763461
- GRCh38:
- Chr15:40471262
| CHST14 | P17S | Cardiovascular phenotype | Uncertain significance (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763470
- GRCh38:
- Chr15:40471271
| CHST14 | R20W | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
| Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763471
- GRCh38:
- Chr15:40471272
| CHST14 | R20P | Cardiovascular phenotype | Uncertain significance (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763473
- GRCh38:
- Chr15:40471274
| CHST14 | A21S | Cardiovascular phenotype | Uncertain significance (Nov 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763473
- GRCh38:
- Chr15:40471274
| CHST14 | A21T | Ehlers-Danlos syndrome, musculocontractural type 1 | Uncertain significance (Jan 24, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763477
- GRCh38:
- Chr15:40471278
| CHST14 | L22P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763483
- GRCh38:
- Chr15:40471284
| CHST14 | R24L | Cardiovascular phenotype | Uncertain significance (Nov 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763485
- GRCh38:
- Chr15:40471286
| CHST14 | A25S | Cardiovascular phenotype | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763486
- GRCh38:
- Chr15:40471287
| CHST14 | A25D | not provided | Uncertain significance (Apr 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763489
- GRCh38:
- Chr15:40471290
| CHST14 | P26L | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Oct 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763506
- GRCh38:
- Chr15:40471307
| CHST14 | A32P | Cardiovascular phenotype | Uncertain significance (Nov 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763511
- GRCh38:
- Chr15:40471312
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763516
- GRCh38:
- Chr15:40471317
| CHST14 | G35A | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Jun 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763523
- GRCh38:
- Chr15:40471324
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763523
- GRCh38:
- Chr15:40471324
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Feb 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763526
- GRCh38:
- Chr15:40471327
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763527
- GRCh38:
- Chr15:40471328
| CHST14 | | not provided | Likely benign (Jul 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763529
- GRCh38:
- Chr15:40471330
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jan 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763537
- GRCh38:
- Chr15:40471338
| CHST14 | P42L | Cardiovascular phenotype | Uncertain significance (Mar 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763537
- GRCh38:
- Chr15:40471338
| CHST14 | P42R | not provided | Uncertain significance (Aug 22, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763542
- GRCh38:
- Chr15:40471343
| CHST14 | M44V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763546
- GRCh38:
- Chr15:40471347
| CHST14 | L45R | not provided | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763547
- GRCh38:
- Chr15:40471348
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763550
- GRCh38:
- Chr15:40471351
| CHST14 | M46I | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763555
- GRCh38:
- Chr15:40471356
| CHST14 | A48V | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype, not provided
| Uncertain significance (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763556
- GRCh38:
- Chr15:40471357
| CHST14 | | not provided, Ehlers-Danlos syndrome, musculocontractural type | Conflicting interpretations of pathogenicity (May 17, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:40763560
- GRCh38:
- Chr15:40471361
| CHST14 | I50F | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763563
- GRCh38:
- Chr15:40471364
| CHST14 | V51M | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763563
- GRCh38:
- Chr15:40471364
| CHST14 | V51L | not provided, Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype
| Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763565-40763575
- GRCh38:
- Chr15:40471366-40471376
| CHST14 | S53fs | Ehlers-Danlos syndrome, musculocontractural type, not provided | Pathogenic/Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763567
- GRCh38:
- Chr15:40471368
| CHST14 | A52V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763570
- GRCh38:
- Chr15:40471371
| CHST14 | S53Y | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763571-40763572
- GRCh38:
- Chr15:40471372-40471373
| CHST14 | S54fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763583
- GRCh38:
- Chr15:40471384
| CHST14 | L58fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763585
- GRCh38:
- Chr15:40471386
| CHST14 | L58P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763586
- GRCh38:
- Chr15:40471387
| CHST14 | | not provided | Likely benign (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763592
- GRCh38:
- Chr15:40471393
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763595
- GRCh38:
- Chr15:40471396
| CHST14 | E61D | Cardiovascular phenotype | Uncertain significance (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763595
- GRCh38:
- Chr15:40471396
| CHST14 | | not provided | Likely benign (Jun 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763600
- GRCh38:
- Chr15:40471401
| CHST14 | G63D | not provided | Uncertain significance (Nov 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763601
- GRCh38:
- Chr15:40471402
| CHST14 | | Cardiovascular phenotype | Likely benign (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763601
- GRCh38:
- Chr15:40471402
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Likely benign (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763608
- GRCh38:
- Chr15:40471409
| CHST14 | A66T | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763610
- GRCh38:
- Chr15:40471411
| CHST14 | | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
| Conflicting interpretations of pathogenicity (Jun 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:40763614
- GRCh38:
- Chr15:40471415
| CHST14 | M68V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763617
- GRCh38:
- Chr15:40471418
| CHST14 | K69* | Ehlers-Danlos syndrome, musculocontractural type 1 | Pathogenic (Aug 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr15:40763622
- GRCh38:
- Chr15:40471423
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763629
- GRCh38:
- Chr15:40471430
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Apr 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763636
- GRCh38:
- Chr15:40471437
| CHST14 | P75Q | not provided | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763640
- GRCh38:
- Chr15:40471441
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763651
- GRCh38:
- Chr15:40471452
| CHST14 | G80D | not provided, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Nov 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763657
- GRCh38:
- Chr15:40471458
| CHST14 | A82G | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763662
- GRCh38:
- Chr15:40471463
| CHST14 | R84S | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (May 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763664
- GRCh38:
- Chr15:40471465
| CHST14 | | not provided, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763667
- GRCh38:
- Chr15:40471468
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763672
- GRCh38:
- Chr15:40471473
| CHST14 | K89fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763683
- GRCh38:
- Chr15:40471484
| CHST14 | G92fs | not provided | Likely pathogenic (Sep 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763687
- GRCh38:
- Chr15:40471488
| CHST14 | G92V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763695
- GRCh38:
- Chr15:40471496
| CHST14 | L95F | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763700
- GRCh38:
- Chr15:40471501
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype, not provided, not specified | Benign/Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763705
- GRCh38:
- Chr15:40471506
| CHST14 | G98E | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763706
- GRCh38:
- Chr15:40471507
| CHST14 | | Cardiovascular phenotype | Likely benign (Apr 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763707
- GRCh38:
- Chr15:40471508
| CHST14 | D99N | Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1 | Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763709
- GRCh38:
- Chr15:40471510
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763711
- GRCh38:
- Chr15:40471512
| CHST14 | A100V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763713
- GRCh38:
- Chr15:40471514
| CHST14 | D101N | not provided | Uncertain significance (Feb 13, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763715
- GRCh38:
- Chr15:40471516
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763722
- GRCh38:
- Chr15:40471523
| CHST14 | V104M | not provided | Uncertain significance (Dec 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763727
- GRCh38:
- Chr15:40471528
| CHST14 | | Cardiovascular phenotype | Likely benign (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763727
- GRCh38:
- Chr15:40471528
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type 1, Ehlers-Danlos syndrome, musculocontractural type
| Conflicting interpretations of pathogenicity (Jul 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:40763730
- GRCh38:
- Chr15:40471531
| CHST14 | | Ehlers-Danlos syndrome | Uncertain significance (Sep 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763737
- GRCh38:
- Chr15:40471538
| CHST14 | R109W | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763790
- GRCh38:
- Chr15:40471591
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763794
- GRCh38:
- Chr15:40471595
| CHST14 | D128H | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763802
- GRCh38:
- Chr15:40471603
| CHST14 | | Cardiovascular phenotype | Likely benign (Feb 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763810
- GRCh38:
- Chr15:40471611
| CHST14 | Q133P | not provided, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, musculocontractural type
| Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763812
- GRCh38:
- Chr15:40471613
| CHST14 | R134W | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (May 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763813
- GRCh38:
- Chr15:40471614
| CHST14 | R134Q | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763815
- GRCh38:
- Chr15:40471616
| CHST14 | R135G | | no interpretation for the single variant | no interpretation for the single variant |
| - GRCh37:
- Chr15:40763821
- GRCh38:
- Chr15:40471622
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Nov 20, 2021) | criteria provided, single submitter |